In addition, transient expression of PTEN with wild-type AR suppresses AR activity on androgen-activated MMTV or GRE driven reporters in DU145 and PC-3 prostate cancer cell lines [37, 38]. The gene discussed is AR; the disease is prostate carcinoma.